Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine

SIMPLE SUMMARY: Colorectal cancer (CRC) begins when normal cells turn out of balance, and a tumor is formed in the lining of the colon or rectum. Cytotoxic T-lymphocyte protein 4 (CTLA-4) is a potent molecule that could inhibit T cell activation. Here, we analyzed this molecule in the tissue samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Derakhshani, Afshin, Hashemzadeh, Shahryar, Asadzadeh, Zahra, Shadbad, Mahdi Abdoli, Rasibonab, Farnaz, Safarpour, Hossein, Jafarlou, Vahid, Solimando, Antonio Giovanni, Racanelli, Vito, Singh, Pankaj Kumar, Najafi, Souzan, Javadrashid, Darya, Brunetti, Oronzo, Silvestris, Nicola, Baradaran, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155910/
https://www.ncbi.nlm.nih.gov/pubmed/34067631
http://dx.doi.org/10.3390/cancers13102414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155910/
https://www.ncbi.nlm.nih.gov/pubmed/34067631
http://dx.doi.org/10.3390/cancers13102414

Ejemplares similares